Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. ________)*
Tenon Medical, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
88066N204
(CUSIP Number)
Jeremy Wilson, Kovitz Investment Group Partners LLC;
71 South Wacker Drive, Ste 11860
Chicago, IL 60606
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
07/01/2024
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
? Rule 13d-1(b) XX ? based on IA status.
? Rule 13d-1(c)
? Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures
provided in a prior cover page.
The information required on the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).
?
CUSIP No. 88066N204
13G
Page 2 of 3 Pages
Kovitz Investment
Group, LLC
1.
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES
ONLY)
47-5657416
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a) ?
(b) ?
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
USA
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5.
SOLE VOTING POWER
0 * Kovitz does not have proxy voting authority
over client accounts.
6.
SHARED VOTING POWER
0
7.
SOLE DISPOSITIVE POWER
939,888* assumes warrants held by Kovitz
clients exercised.
8.
SHARED DISPOSITIVE POWER
939,888 * assumes warrants held by Kovitz
clients exercised.
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
939,888 * assumes warrants held by Kovitz clients
exercised.
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES
(see instructions) ?
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
21.89%
12.
TYPE OF REPORTING PERSON (see instructions)
IA
Item 1.
(a)
Name of Issuer:
Tenon Medical, Inc.
(b)
Address of Issuer?s Principal Executive Offices
104 Cooper Court, Los Gatos, CA 95032
Item 2.
(a)
Name of Person Filing
Kovitz Investment Group Partners, LLC
(b)
Address of the Principal Office or, if none, residence
71 S. Wacker Drive, Suite 1860, Chicago, IL 60606
CUSIP No. 88066N204
13G
Page 3 of 3 Pages
(c)
Citizenship
USA
(d)
Title of Class of Securities
Common Stock
(e)
CUSIP Number
88066N204
Item 3. If this statement is filed pursuant to ??240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
?
Broker or dealer registered under section 15 of the Act
(15 U.S.C. 78o).
(b)
?
Bank as defined in section 3(a)(6) of the Act (15 U.S.C.
78c).
(c)
?
Insurance company as defined in section 3(a)(19) of the
Act (15 U.S.C. 78c).
(d)
?
Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8).
XX
(e)
?
An investment adviser in accordance with ?240.13d-
1(b)(1)(ii)(E);
(f)
?
An employee benefit plan or endowment fund in accordance
with ?240.13d-1(b)(1)(ii)(F);
(g)
?
A parent holding company or control person in accordance
with ?240.13d-1(b)(1)(ii)(G);
(h)
?
A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
?
A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the
Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
?
Group, in accordance with ?240.13d-1(b)(1)(ii)(J).
Item 4. Ownership.
Provide the following information regarding the aggregate number
and percentage of the class of securities of the issuer
identified in Item 1.
(a)
Amount beneficially owned: 939,888 * assumes warrants held
by Kovitz clients exercised
(b)
Percent of class: 21.89%
(c)
Number of shares as to which the person has: 939,888
(i)
Sole power to vote or to direct the vote . 0
(ii)
Shared power to vote or to direct the vote . 0
(iii)
Amount beneficially owned: 939,888 * assumes warrants
held by Kovitz clients exercised
(iv)
Shared power to dispose or to direct the disposition
of . 0
Instruction. For computations regarding securities which
represent a right to acquire an underlying security see
?240.13d-3(d)(1).
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following ? .
Instruction. Dissolution of a group requires a response to this
item.
Item 6. Ownership of More than Five Percent on Behalf of
Another Person.
Item 7. Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on By the Parent
Holding Company.
Item 8. Identification and Classification of Members of the
Group.
Item 9. Notice of Dissolution of Group.
Item 10. Certification.
(a)
The following certification shall be included if the
statement is filed pursuant to ?240.13d-1(b):
By signing below I certify that, to the best of my
knowledge and belief, the securities referred to above
were acquired and are held in the ordinary course of
business and were not acquired and are not held for the
purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not
acquired and are not held in connection with or as a
participant in any transaction having that purpose or
effect.
(b)
The following certification shall be included if the
statement is filed pursuant to ?240.13d-1(c):
By signing below I certify that, to the best of my
knowledge and belief, the securities referred to above
were not acquired and are not held for the purpose of or
with the effect of changing or influencing the control of
the issuer of the securities and were not acquired and are
not held in connection with or as a participant in any
transaction having that purpose or effect.
After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this
statement is true, complete and correct.
08/08/2024
Date
/s/
Signature
Jeremy Wilson, CCO
Name/Title